Streetbeat News

Regulatory

UUP

June retail sales in the U.S. stagnated, leading traders to fully price in a September interest rate cut. The U.S. Dollar Index rose slightly, and Treasury yields trimmed losses. Fed Chair Jerome Powell's dovish comments and a potential weakening labor market could prompt the Fed to lower rates.

Portfolio Pulse from Piero Cingari

July 16, 2024 | 12:54 pm

AMZN

The FTC has requested details from Amazon regarding its plan to hire from Adept, focusing on the recent announcement of Adept CEO David Luan joining Amazon and the licensing of Adept's technology. This inquiry is part of a broader review of Big Tech partnerships with AI startups and does not necessarily indicate an official investigation or enforcement action.

Portfolio Pulse from Benzinga Newsdesk

July 16, 2024 | 12:35 pm

CVLT

Commvault Cloud has been listed in the AWS Marketplace for the U.S. Intelligence Community (ICMP), making it available to U.S. Government customers. This listing was done in collaboration with Carahsoft Technology Corp.

Portfolio Pulse from Benzinga Newsdesk

July 16, 2024 | 12:35 pm

HOTH

Hoth Therapeutics has received approval to proceed with a Phase 2a clinical trial of HT-001, aimed at treating skin toxicities associated with epidermal growth factor receptor inhibitors. Three new sites, GW University Hospital, UC Irvine, and Northwell Health, have joined the trial.

Portfolio Pulse from Benzinga Newsdesk

July 16, 2024 | 12:34 pm

LGCL

Lucas GC Limited (NASDAQ:LGCL) has received a new invention patent in China for 'Artificial Intelligence Enabled Prescriptive Persuasion Processes Based on Speech Emotion Recognition and Sentiment Analysis.' This is the company's second patent in 2024, bringing their total to eighteen.

Portfolio Pulse from Benzinga Newsdesk

July 16, 2024 | 12:34 pm

CENN

Cenntro Electric Group Limited has received an Executive Order from the California Air Resources Board and a Certificate of Conformity from the EPA for its Logistar 300 model. This approval allows the vehicle to be sold and operated in California and other states that follow CARB standards.

Portfolio Pulse from Benzinga Newsdesk

July 16, 2024 | 12:33 pm

ICU

SeaStar Medical Holding Corporation (NASDAQ:ICU) received a Category B Coverage Letter from the U.S. CMS for its NEUTRALIZE-AKI pivotal trial. This will cover a portion of the trial costs and is expected to accelerate medical site activations.

Portfolio Pulse from Benzinga Newsdesk

July 16, 2024 | 12:32 pm

BDRX

Biodexa shares are trading higher following Health Canada's approval of a Phase 2a dose confirmation study of Tolimidone for Type 1 diabetes.

Portfolio Pulse from Benzinga Newsdesk

July 16, 2024 | 12:32 pm

BDRX

Biodexa Pharmaceuticals announced that Health Canada has approved a Phase 2a dose confirmation study of Tolimidone in Type 1 Diabetes. This approval marks a significant milestone for the company in advancing its clinical pipeline.

Portfolio Pulse from Benzinga Newsdesk

July 16, 2024 | 12:31 pm

JCSE

JE Cleantech Holdings Limited (NASDAQ:JCSE) has been granted a temporary exception by Nasdaq to remain listed. The company must obtain shareholder approval for a reverse stock split by November 14, 2024, and maintain a $1 closing bid price for ten consecutive business days by December 6, 2024, to comply with Nasdaq's Bid Price Rule.

Portfolio Pulse from Benzinga Newsdesk

July 16, 2024 | 12:26 pm